Enzo Life Sciences Launches New Compound Library to Provide Essential Standards for stem cell regulatory and signaling pathway screening

Enzo Life Sciences is proud to introduce the SCREEN-WELL® Stem Cell Library, a collection of 130 readyto-use compounds for diverse stem cell research.

Enzo Life Sciences, Inc.
Jul 8, 2019

It contains small molecules that can be used to investigate cellular mechanisms that regulate differentiation, self-renewal, reprogramming, and cell growth. The structural and mechanistic differences can help unlock cellular mechanism that can hold promises for new cellular therapies, regenerative medicine, and improving model systems to access drug efficacy and toxicity. The SCREEN-WELL® Stem Cell Library builds upon Enzo’s collection of stem cell research solutions which includes DNA labeling kits for genomic analysis, enzyme activity kits, detection kits for cellular analysis, and immunoassays and antibodies for biomarker detection. 

The SCREEN-WELL® Stem Cell Library is comprised of compounds that are predominantly dissolved at 10 mM in DMSO and aliquoted at 100 µL per well in deep 96-well plates. The SCREEN-WELL® Compound Libraries include complete documentation that highlights the physical information and mechanism of action for each compound. In addition, Enzo has the ability to re-supply individual bulk compounds or to build custom libraries. 

The comprehensive SCREEN-WELL® Stem Cell Library is the newest addition to Enzo’s portfolio of SCREEN-WELL® Compound Libraries, which are unique collections of small molecules provided in a ready-to-use format, amenable to high-throughput screening. Our extensive list of compound libraries includes the SCREEN-WELL® FDA approved drug library, toxicity libraries, kinase inhibitor libraries, and more